Picard Medical is trading $4.90 (+11.11%) with no company-specific catalyst identified.
- No company-specific announcement dated September 10, 2026 has been identified.
- August 19 results showed 39% quarterly revenue growth, but are not a new catalyst.
- Broader markets are lower amid inflation and rate concerns, while Picardβs gain moves against that trend.